Suchergebnisse - "Cortellini, Alessio"

PubPharm (260)

1

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Leonetti, A. | Perrone, F. | Puntoni, M. | +43

2

Safety and preliminary efficacy of pembrolizumab following trans-arterial chemoembolization for hepatocellular carcinoma : the PETAL phase Ib study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Pinato, D. | D'Alessio, A. | Fulgenzi, C. | +21

3

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes

enthalten in: Journal for immunotherapy of cancer | 2024

von Nassar, A. | El Zarif, T. | Khalid, A. | +31

4

Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors : A Multicenter Cohort Study

enthalten in: The oncologist | 2024

von Pecci, F. | Cantini, L. | Cognigni, V. | +24

5

APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies : Integration of Real-World Data and Translational Research

enthalten in: Clinical lung cancer | 2024

von Prelaj, A. | Ganzinelli, M. | Provenzano, L. | +63

6

Association of Survival With Immune-Related Adverse Events-Time to Consider the Duration of Treatment

enthalten in: JAMA dermatology | 2024

von Fujiwara, Y. | Cortellini, A. | Naqash, A.

7

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer : Results of a propensity-matched analysis of the OnCovid registry

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Mostaghim, A. | Minkove, S. | Aguilar-Company, J. | +43

8

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

enthalten in: Journal of hepatology | 2024

von Celsa, C. | Cabibbo, G. | Fulgenzi, C. | +69

9

Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Hedayat, S. | Cascione, L. | Cunningham, D. | +43

10

Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade : a systematic review and meta-analysis of randomised controlled trials

enthalten in: The Lancet. Oncology | 2024

von Fujiwara, Y. | Horita, N. | Adib, E. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]